Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2020 Earnings Conference Call March 23, 2021 4:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - Chief Executive Officer Maged Shenouda - Chief Financial Officer Conference Call Participants Andrew Tsai - Jefferies Marc Goodman - Leerink Joon Lee - Truist Securities Jay Olson - Oppenheimer Operator Greetings. Welcome to the Relmada Therapeutics Incorporated Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this t ...